Deanna J. Buehrle

Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure

Deanna J. Buehrle, Ryan K. Shields, Lloyd Clarke et al. · Antimicrobial Agents and Chemotherapy · 2016 · 121 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Prevalence of Inappropriate Antibiotic Prescribing in Primary Care Clinics within a Veterans Affairs Health Care System

Nathan R Shively, Deanna J. Buehrle, Cornelius J. Clancy et al. · Antimicrobial Agents and Chemotherapy · 2018 · 119 citations · Full text

Pharmacy, Family Medicine, Pharmacotherapy +13

PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates

Cornelius J. Clancy, Deanna J. Buehrle, M. Hong Nguyen · JAC-Antimicrobial Resistance · 2020 · 102 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Evaluation of the <i>In Vitro</i> Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates

Deanna J. Buehrle, Ryan K. Shields, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2016 · 95 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data

Cornelius J. Clancy, Brian A. Potoski, Deanna J. Buehrle et al. · Open Forum Infectious Diseases · 2019 · 66 citations · Full text

Pharmacy, Hospital Pharmacy, Pharmacotherapy +17